Evidence map›Paper›PMID 37779700›Full record

ArticleFrontiers in microbiology2023

Validation of flavivirus infectious clones carrying fluorescent markers for antiviral drug screening and replication studies.

Liubov Cherkashchenko, Nathalie Gros, Alice Trausch, Aymeric Neyret, Mathilde Hénaut, Gregor Dubois, Matthieu Villeneuve, Christine Chable-Bessia, Sébastien Lyonnais, Andres Merits and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Liubov CherkashchenkoCEMIPAI UAR3725 CNRS, University of Montpellier, Montpellier, France.
Nathalie GrosCEMIPAI UAR3725 CNRS, University of Montpellier, Montpellier, France.
Alice TrauschCEMIPAI UAR3725 CNRS, University of Montpellier, Montpellier, France.
Aymeric NeyretCEMIPAI UAR3725 CNRS, University of Montpellier, Montpellier, France.
Mathilde HénautCEMIPAI UAR3725 CNRS, University of Montpellier, Montpellier, France.
Gregor DuboisCEMIPAI UAR3725 CNRS, University of Montpellier, Montpellier, France.
Matthieu VilleneuveCEMIPAI UAR3725 CNRS, University of Montpellier, Montpellier, France.
Christine Chable-BessiaCEMIPAI UAR3725 CNRS, University of Montpellier, Montpellier, France.
Sébastien LyonnaisCEMIPAI UAR3725 CNRS, University of Montpellier, Montpellier, France.
Andres MeritsInstitute of Technology, University of Tartu, Tartu, Estonia.
Delphine MuriauxCEMIPAI UAR3725 CNRS, University of Montpellier, Montpellier, France.
Centre National de la Recherche Scientifique · FRUniversité de Montpellier · FRUniversity of Tartu · EE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Flaviviruses have emerged as major arthropod-transmitted pathogens and represent an increasing public health problem worldwide. High-throughput screening can be facilitated using viruses that easily express detectable marker proteins. Therefore, developing molecular tools, such as reporter-carrying versions of flaviviruses, for studying viral replication and screening antiviral compounds represents a top priority. However, the engineering of flaviviruses carrying either fluorescent or luminescent reporters remains challenging due to the genetic instability caused by marker insertion; therefore, new approaches to overcome these limitations are needed. Here, we describe reverse genetic methods that include the design and validation of infectious clones of Zika, Kunjin, and Dengue viruses harboring different reporter genes for infection, rescue, imaging, and morphology using super-resolution microscopy. It was observed that different flavivirus constructs with identical designs displayed strikingly different genetic stabilities, and corresponding virions resembled wild-type virus particles in shape and size. A successful strategy was assessed to increase the stability of rescued reporter virus and permit antiviral drug screening based on quantitative automated fluorescence microscopy and replication studies.

Indexed as

dengue virusflavivirusesfluorescent marker and reporter genesinfectious cloneKunjin virusreverse geneticsZika virus

Identifiers

PMID37779700
PMCPMC10541152
OpenAlexW4386836582

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.